TSH Target in Hashimoto's Thyroiditis
For non-pregnant adults with Hashimoto's thyroiditis, target TSH within the normal reference range of 0.45-4.12 mIU/L, as evidence does not support targeting specific values within this range. 1 For pregnant women or those trying to conceive, maintain TSH <2.5 mIU/L in the first trimester, <3.0 mIU/L in the second trimester, and <3.5 mIU/L in the third trimester. 1
Non-Pregnant Adults
The guideline evidence is clear and direct: apart from pregnant patients, there is no benefit to targeting specific TSH values within the normal reference range 1. This means:
- Target range: 0.45-4.12 mIU/L (based on NHANES III reference population)
- Do not aim for the lower end of normal (e.g., TSH <2.5 mIU/L) unless the patient is pregnant or planning pregnancy
- Adjust levothyroxine dosing to achieve any value within this range based on clinical response
Key Nuance on TSH Upper Limit
While some have proposed lowering the upper TSH limit to 2.5-3.0 mIU/L, the guidelines explicitly reject this approach for non-pregnant patients 1. The reasoning:
- Treating patients with TSH 2.5-4.12 mIU/L would create over 10 million additional hypothyroidism diagnoses annually in the U.S. without proven clinical benefit
- TSH naturally varies up to 50% above and below an individual's mean value on any given day
- Many patients with TSH in this range do not have early hypothyroidism
Clinical Pitfall: Do not over-treat based on a single TSH value between 2.5-4.12 mIU/L in non-pregnant patients. This represents normal physiologic variation in most cases.
Pregnancy and Preconception
The targets are substantially different and more stringent for pregnant women:
Trimester-Specific Targets 1
- First trimester: TSH <2.5 mIU/L
- Second trimester: TSH <3.0 mIU/L
- Third trimester: TSH <3.5 mIU/L
Women Planning Pregnancy 2
- Preconception target: TSH ≤2.5 mIU/L before attempting conception
- Immediately increase levothyroxine dose by 30% (typically two additional tablets per week) upon missed menstrual period or positive pregnancy test
- Check TSH promptly after conception and adjust accordingly
Monitoring During Pregnancy 1
- Measure TSH every 4 weeks during first half of pregnancy
- Measure at least once between 26-32 weeks gestation
- Women with Hashimoto's typically require 30-50% dose increase during pregnancy
Evidence Supporting Stricter Pregnancy Targets
Recent research confirms the importance of these lower targets. A 2023 study found that approximately 30% of Hashimoto's patients with preconception TSH ≤2.5 mIU/L still developed first-trimester TSH >2.5 mIU/L 3. The study identified optimal preconception TSH cutoffs of:
- 1.24 mIU/L for hypothyroid patients on levothyroxine
- 1.73 mIU/L for euthyroid Hashimoto's patients
These lower preconception targets may better prevent first-trimester thyroid insufficiency, though the established guideline target remains ≤2.5 mIU/L 2.
Special Considerations
Consultation with Endocrinology 1
Refer patients in these situations:
- Pregnancy or planning conception
- Difficulty achieving or maintaining target TSH
- Presence of goiter, nodules, or structural thyroid changes
- Coexisting cardiac disease
- Other endocrine disorders
Dosing Adjustments 1
- Young healthy adults: Consider starting full replacement doses
- Patients >50-60 years without cardiac disease: Start with 50 µg daily
- Subclinical hypothyroidism: Start with 25-75 µg daily depending on TSH elevation
Critical Point: The evidence does not support the common practice of targeting TSH in the lower-normal range for symptom relief in non-pregnant Hashimoto's patients. Quality of life improvements have not been demonstrated with TSH suppression below the normal range in this population 1.